EP3849625A1 - System for analysing fluids originating from the body or fluids in contact with fluids originating from the body - Google Patents
System for analysing fluids originating from the body or fluids in contact with fluids originating from the bodyInfo
- Publication number
- EP3849625A1 EP3849625A1 EP19769417.7A EP19769417A EP3849625A1 EP 3849625 A1 EP3849625 A1 EP 3849625A1 EP 19769417 A EP19769417 A EP 19769417A EP 3849625 A1 EP3849625 A1 EP 3849625A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- liquid
- line
- fluid
- collection
- bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 44
- 238000012360 testing method Methods 0.000 claims abstract description 115
- 239000012491 analyte Substances 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims description 113
- 210000002700 urine Anatomy 0.000 claims description 27
- 210000004369 blood Anatomy 0.000 claims description 26
- 239000008280 blood Substances 0.000 claims description 26
- 210000001124 body fluid Anatomy 0.000 claims description 16
- 239000010839 body fluid Substances 0.000 claims description 16
- 230000004888 barrier function Effects 0.000 claims description 6
- 206010048629 Wound secretion Diseases 0.000 claims description 5
- 239000000385 dialysis solution Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 11
- 238000005070 sampling Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 7
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 238000005353 urine analysis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/22—Fuels; Explosives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/1032—Determining colour for diagnostic purposes
- A61B5/1034—Determining colour for diagnostic purposes by means of colour cards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/15003—Source of blood for venous or arterial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150366—Blood collection bags, e.g. connected to the patient by a catheter comprising means for removing a small sample of collected blood from the bag
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150992—Blood sampling from a fluid line external to a patient, such as a catheter line, combined with an infusion line; blood sampling from indwelling needle sets, e.g. sealable ports, luer couplings, valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/69—Drainage containers not being adapted for subjection to vacuum, e.g. bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3324—PH measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
- A61M2205/584—Means for facilitating use, e.g. by people with impaired vision by visual feedback having a color code
Definitions
- the invention relates to a system for analyzing liquids originating from the body with a volume through which the liquid flows, in particular with a liquid line and / or a liquid storage volume, and a system that is integrated in the system and can be connected or connected to the volume
- Sensor unit for the detection of at least one analyte in the liquid and / or at least one parameter of the liquid. It also affects one
- Removal device for taking samples of liquids originating from the body with a sample volume, a sensor unit with the
- Sample volume is connected or connectable.
- Permanent transurethral catheters are one of the most frequently used care utensils in everyday clinical practice. Due to possible flan tract infections, there is a need for regular monitoring.
- a urine analysis can be carried out, for example, by immersing commercially available test strips in the urine in a test vessel. These test strips have test fields that change their color
- Health status of the patient can be taken.
- an analysis device for analyzing urine which can be connected to a urine collection container and has: a) a discrete test section for performing a colorimetric test, each test section being designed to carry out a different colorimetric test, b ) a color sensor for reading out the test section and for outputting an indication based on the presence of an analyte and c) an integrated circuit for obtaining a display of the color sensor and calculating a quantity of the analyte in the urine. Solutions of this type with optical sensors are generally quite complex and expensive and are therefore less suitable for day-to-day hospital use with limited costs.
- WO 2018 058 077 A1 discloses a sensor connector for connecting a urine bag and a catheter in order to determine the pH value and a nitrite concentration, the connector being a hollow body which forms a passage for the urine and a first end for connecting to the catheter and has a second end for connection to the line of the urine bag, and a pH sensor connected to the connector as a hydrogel and / or a nitrite sensor with plasmonic nanoparticles for detecting bacteria in the urine flowing through the passage, the pH sensor reversibly provides a colorimetric change based on the pH of the urine, and the nitrite sensor provides a colorimetric change based on the nitrite concentration of the urine.
- a disadvantage of this system is that an exchange of the connector requires an opening of the otherwise closed system, which involves the risk of germs entering the system or the catheter.
- test vessels have been used to carry out analyzes using conventional test strips, into which a sample of urine from a urine bag is filled.
- the test vessels disadvantageously represent a potential source of infection for the nursing staff.
- urine can drip onto the floor, which must then be removed and adversely affect hygiene in the hospital.
- Such a urine withdrawal which is currently common in everyday clinical practice, also involves a certain amount This means more work for the nursing staff. Due to time constraints, it is not uncommon that urine analysis does not take place and a possible infection of the patient is recognized too late.
- Urine bags or tube systems that are already equipped with test fields have the disadvantage that they have to be replaced quite quickly after contact with liquid, since the test fields can usually only be used once.
- the present invention is based on the object of eliminating the disadvantages mentioned above, in particular a device for analyzing from the body
- this object is achieved by a system according to claim 1, in particular a system for analyzing liquids originating from the body with a volume through which the liquid flows, in particular with a
- Liquid line and / or a liquid storage volume and an integrated in the system and connected to the volume or connectable
- Sensor unit for the detection of at least one analyte of the liquid and / or at least one parameter of the liquid, wherein the sensor unit has or is a test strip with at least one test field, which is in the presence of an analyte to be recorded and / or as a function of a parameter to be recorded Liquid stains.
- the task is also solved by a
- Removal device in particular a removal device for taking samples of liquids originating from the body with a sample volume, a sensor unit being connected or connectable to the sample volume, the sensor unit having or being a test strip with at least one test field that is in the presence of an analyte to be detected and / or depending on a parameter of the liquid to be detected. Under a liquid coming from the body are next to direct
- Body fluids such as urine, cerebrospinal fluid, tear fluid or aqueous humor
- Nasal secretions sputum (saliva), pleural fluid, gastric juice, pancreatic secretions, bile, vaginal secretions, menstrual fluid, cervical mucus, amniotic fluid,
- Parameters that can be determined with the aid of the system according to the invention include nitrite (this is formed by some germs from nitrate and therefore indicates a urinary tract infection), urobilinogen (arises from bilirubin and indicates as a breakdown product of hemoglobin to liver disease) ), Erythrocytes (indicate inflammation of the urinary tract), leukocytes (may occur if the kidney or bladder is inflamed), proteins (including albumin, in particular, indicate kidney disease), pH (an alkaline pH value occurs Urinary tract infections, an acidic pH value indicates diabetes), ketones (indicate increased fat loss in metabolic diseases), glucose (indicates diabetes and can also occur in some types of cancer), density (can include kidney disease) indicate if the density remains low despite low fluid intake), ascorbic acid (does not provide any information on the Health of the patient, but can measure other parameters
- test strips with test fields that change their color in the presence of an analyte to be examined and its concentration are in particular in medical collecting bags and / or tubes or sample containers that can be opened or removed or connected, test strips with test fields that change their color in the presence of an analyte to be examined and its concentration.
- the invention has the following advantages in particular.
- Any bacterial infection of the patient can be quickly identified by rapid measurement (continuously, quasi-continuously or as required) and thus treated promptly
- the liquid located in a separate sampling and testing device can be used for further analysis, so that additional sampling is not required
- the liquid line is a catheter, a line tube for guiding body fluid into a collecting container, a bypass tube, a connector piece for connecting a catheter to a line tube or an extracorporeal blood line.
- the liquid storage volume can in particular be a
- the liquid line and / or the liquid storage volume can be designed or provided with a bypass in which the test strip is located. If necessary, liquid to be examined can be passed through the bypass so that the test strip
- the bypass is exchangeably connected to the liquid line or to the liquid storage volume.
- bypass with the test strip can be exchanged particularly easily without having to separate the catheter from the collecting bag.
- the collection bag and catheter are connected to the patient over a longer period of time and the test strip has test fields with an irreversible color change property.
- a bypass with integrated Test strips can also be part of a connector piece.
- the bypass is preferably connected to an integrated test strip by penetrating a self-sealing membrane. This has the advantage that the bypass can be removed and replaced without leakage.
- a further embodiment of the device is characterized in that the system comprises at least one sample container, one with which the
- Liquid flow volume is connected or is connectable and in which the test strip is arranged.
- the volume of the sample container is preferably not permanent, but is only filled with the liquid to be analyzed for the purpose of measurement or analysis. In this way, accidental contact of the
- Test strip with liquid and premature consumption of the test strip can be avoided.
- the sample container can preferably form a sample volume in which the test strip is arranged or to which the test strip is fluidly connected.
- the sample volume can in particular be sealed off from the volume of the system through which liquid flows by means of a barrier.
- the sample container can in particular be filled with a preferably isotonic solution.
- the barrier can in particular be formed or arranged on the liquid storage volume and / or on the liquid line. Preferably that is
- flowable volume can be fluidically connected. In this way, a measurement / analysis can be carried out in a particularly simple manner to one desired by medical personnel
- the barrier is preferably a clamp
- the sample container can consist of rigid, semi-rigid or flexible material. It is preferably arranged directly and immediately on a collection container or collection container for body fluid, in particular collection bags or collection bags for urine, blood, wound secretions or other.
- the sample container can in particular be a bag, for example a tubular bag. Alternatively, it can be in the form of a protuberance of a liquid storage volume designed as a bag.
- the sample container can be separated and removed from the volume through which liquid flows. This has the advantage that no new sampling is necessary if the
- Liquid to be examined in the sample container is to be examined in more detail with an external analysis system.
- a further embodiment of the invention is characterized in that the sample container is non-positively and / or positively and / or materially connected to the liquid storage volume or to the liquid line.
- the sample container can be connected to or separated from the volume of the system through which liquid flows, in a particularly simple manner, which makes the system particularly user-friendly.
- the sample container is designed as a syringe, in particular a single-use syringe, with a syringe cylinder and a syringe plunger that is movably received therein and limits a variable sample volume.
- the object on which the present invention is based is achieved by a system for analyzing from the body
- a fluid line and collecting device ie, a volume through which liquid flows
- a liquid line in particular a hose
- a liquid storage volume in particular a Liquid bag
- a sensor unit connected or connectable to the fluid line and collection device for detecting at least one analyte in the liquid and / or at least one parameter of the liquid, which sensor unit has or is a test strip with at least one test field that is in Presence of an analyte to be detected and / or depending on a parameter to be detected of the liquid colors, furthermore with at least one attachment (with the sample container) that can be or is mounted fluidically and releasably on the fluid line and collection device, which serves as a carrier for the Sensor unit is formed.
- a sampling device for taking samples of liquids originating from the body with a sample container, in which a sensor unit is arranged, which has or is a test strip with at least one test field, which can be detected in the presence of one
- the removal device being designed as an attachment which is detachably mounted or mountable on a fluid line and collection device and fluidly connected or connectable thereto.
- the cultivation is to be understood in particular in such a way that this one to the
- Fluid line and collection device is a separate component.
- the attachment is from the fluid line and collection device
- Removable / detachable / removable / separable mounted or mountable on it that when removing / releasing / disassembling / separating the extension or when mounting it on or on the fluid line and collection device, operation or use of the fluid line and collection device is not or only slightly is impaired, ie, a liquid flow through or into the fluid line and collection device does not have to be interrupted in order to loosen or mount the attachment. That is, the
- Fluid line and collection device is by mounting or loosening the
- the attachment preferably has a single connection at which it connects to the fluid line and collection device is connectable or connected, or the attachment alternatively has exactly two connections in order to connect the attachment with both connections to the fluid line and collection device such that it can be flowed through in the manner of a bypass.
- FIG. 1 is a schematic representation of a fluid system with a bag for collecting a body fluid with a test strip
- FIG. 2 shows a schematic representation of a test strip of the system of FIG. 1,
- FIG. 3 shows a schematic representation of a liquid system with a bag for collecting body fluid and a test strip arranged in a liquid line leading to the bag at different positions
- Fig. 4 is a schematic representation of a fluid system with a bag for collecting body fluid and one in a connector
- FIG. 5 shows a schematic representation of an alternative embodiment of a bag according to the invention
- Fig. 6 shows a further alternative in a schematic representation
- Fig. 7 shows a further alternative in a schematic representation
- FIG. 8 shows a schematic representation of a device for extracorporeal blood treatment with a device according to the invention
- FIG. 9 shows a schematic representation of a fluid system with a bag for collecting body fluid and a test strip arranged in a bypass.
- FIG. 1 shows an example of a liquid system with a bag 1 for
- the bag 1 can be designed as a collecting bag 1 or a collecting bag 1 and forms a liquid space 2, which can also be referred to as a collecting space 2, is provided with a drain valve 3 and via a flexible liquid line 4, here in the form of a hose 4 Connector piece 5 connected.
- the connector piece 5 is connected to a catheter 6 on the side opposite the hose 4. In the present case, this can in particular be a transurethral
- the catheter 6 although not shown in this way in the figure, can be in the form of a catheter 6 according to Nelaton, Tiemann, Mercier, Couvelaire, Dufouer, Frohmüller, Pezzer, Casper, Malecot and / or Stöer or modifications thereof.
- the catheter 6 shown in FIG. 1 is a Foley catheter 6 and has a balloon 7 for fixation in the bladder of a patient.
- a condom urinal is also conceivable and is within the scope of the invention.
- Liquid can be drained from the liquid space 2 of the bag 1 via the drain valve 3.
- the drain valve 3 arises at the lower edge of the bag 1 from the bag space 2, into which the hose 4 opens at the upper edge of the bag 1.
- At least one sensor unit 100 in the form of a test strip 100 is arranged, in particular attached, in the bag space 2.
- the test strip 100 has at least one test field 101-111 which changes its color in the presence of an analyte to be examined and / or its concentration.
- Such a test strip 100 is shown by way of example in FIG. 2.
- the test strip 100 shown in FIG. 2 has, for example, a test field 101 for determining the pFI value, a further test field 102 for determining nitrite, a further test field 103 for determining urobilinogen, a further test field 104 for determining erythrocytes, and a further test field 105 to determine
- Leukocytes another test field 106 for the determination of proteins, another test field 107 for the determination of ketones, another test field 108 for the determination of glucose, a further test field 109 for determining ascorbic acid, a further test field 110 for displaying blood and a further test field 111 for
- test fields are exemplary and in particular the number of test fields as well as the parameters detected by means of these can vary within the scope of the invention. In particular, only a part of these test fields on the
- test strips or a redundant design are available.
- FIG. 2 shows the test fields 101-111 on the test strip 100 in row form, but an arrangement of test fields 100 in matrix form is also within the scope of the invention.
- a design of the test strip 100 in the form of a ring is within the scope of the invention.
- This embodiment of the test strip 100 is particularly advantageous when the test strip 100 is in a cylindrical container.
- Reference color chart can be used, with which it can be compared whether and if so in what concentration an analyte is present in the liquid to be examined. The same applies to the pFI value and the density of the liquid.
- the reference color chart is preferably located in the vicinity of the test strip or is arranged in the vicinity of the test strip.
- FIG. 3 shows a modified embodiment of the liquid system 1, which essentially corresponds to the embodiment according to FIG. 1, so that reference is made to the relevant description and only deviations are described below.
- the liquid system 1 of FIG. 3 there are two
- test strip 100 different positions for the test strip 100 are shown, of which only one or both can be provided with a test strip 100. Accordingly, a first test strip (100a) can be arranged in the liquid line 4, also here as a hose 4, between the bag 1 and the connector piece 5.
- a second test strip 100b can be arranged directly on the catheter 6 itself.
- a further embodiment not shown in the figures, has the test strip 100 in the bag 1, the first test strip 100a in the tube 4 and the second test strip 100b in the catheter 6.
- a further embodiment is shown in FIG. 4, in which the test strip 100 is arranged on a connector / connector piece 5 or is integrated into the connector 5 as a component thereof. The connector 5 and thus also the test strip 100 are thus arranged between the tube 4 and the catheter 6.
- An embodiment is advantageous in that conventional collecting bags 1 and catheters 6 can continue to be used.
- the connector 5 can advantageously be designed as a separate consumable.
- FIG. 5 A further embodiment, which enables medical personnel to carry out a quick measurement when required or, for example, when a bacterial infection is suspected, is shown in FIG. 5.
- the collecting bag 1 is designed or equipped with sample containers 8a, 8b, 8c.
- sample containers 8a, 8b, 8c In each of the
- Sample containers 8a, 8b, 8c, a sensor unit 200 is arranged in the form of a test strip 200a, 200b, 200c, each with at least one test field.
- Sample containers 8a, 8b, 8c can be made of rigid or semi-rigid or flexible
- Be formed material and has a sample volume that compared to
- Liquid space 2 of the bag 1 is sealed in a liquid-tight manner.
- Liquid space in the form of a weld seam, peel seam, adhesive seam or the like. If necessary, the seal between the liquid space 2 and the respective sample volume of the sample containers 8a, 8b, 8c can be removed and a liquid connection can be formed, so that the sample volume is
- Liquid space 2 is open and liquid to be examined can flow in
- the bag 1 shown in FIG. 5 has three sample containers 8a, 8b, 8c on one side, each of which contains a test strip 200a, 200b, 200c, each with variable test fields.
- the contents of the bag from the liquid space 2 can only get into one of the sample containers 8a, 8b, 8c when a fluidic connection has been brought about by an operator. Basically, one can stand out
- sample container 8a, 8b, 8c on any side of the bag 1 and / or on the tube 4 and / or connector 5 and / or catheter 6.
- Another embodiment, which is shown in FIG. 6, has a removable sample container 9. This has the advantage that no new sampling is necessary if the sample in the sample container is to be examined
- FIG. 6 shows an example of a bag 1 with a bag space 2 or liquid space 2, an optional drain valve 3 and a connector unit 10.
- a removable sample container 9 with an integrated test strip 200 is compatible with the connector unit 10 and can be attached to or with the Bag space 2 are connected.
- the connection between the connector unit 10 and the sample container 9 can be non-positive and / or positive and / or material.
- the connector unit 10 may advantageously have a rubber-elastic membrane. This can be pierced by the sample container 9 and effect a seal between the latter and the connector unit 10. After filling and removal of the sample container 9, the membrane can contract again due to its rubber-elastic properties and preferably seal the connector unit 10 independently, so that a
- Connector unit 10 can be closed manually by means of a clamp, not shown in the figures.
- the at least one connector unit 10 can be located at any point on the bag 1 and / or on the tube 4 and / or connector 5 and / or catheter 6.
- FIG. 7 shows a further embodiment of the invention with a removable sample container with integrated test strip 200.
- the sample container is designed here as a particularly connectable removal device in the form of a syringe with a piston 12 and a syringe cylinder 11. It can already be integrated in the bag 1 by the manufacturer, or it can only be connected to the bag 1 by the user before a sample is taken.
- the removal device is or is connected to the liquid space 2 of the bag 1 by means of a preferably self-sealing connector unit 10. By pulling out the piston 12, liquid is sucked into the syringe barrel 11.
- a test strip 200 is arranged in the syringe cylinder 11 and, depending on the presence of an analyte to be detected, the color of its changes at least one test field. It should be pointed out that in this embodiment the connector unit 10 can also be located at any point on the bag 1 and / or on the tube 4 and / or connector 5 and / or catheter 6.
- FIG. 8 shows a simplified arrangement for extracorporeal blood treatment.
- Blood is withdrawn from a patient 300 with the aid of a blood pump 302 and passed through an arterial blood line 301, here in the form of an arterial tube 301, into a dialyzer 303, where it is freed from excess water and substances that require urine and thus cleaned.
- the blood travels back to the patient 300 via a venous blood line 304, here in the form of a venous tube 304.
- the blood treatment machine 305 produces dialysis fluid for the duration of the therapy.
- Dialysis fluid line / fluid line 306 flows counter to the blood direction and flows through the dialyzer 303 separately through a semipermeable membrane. Excess water and urinary substances are removed by the
- Dialysis fluid is added, which then leaves the dialyser 303 as a so-called dialysate through a line / dialysate line / liquid line 307.
- the dialysate is fed via a dialysate line / liquid line 308 into a drain, not shown in detail.
- the dialysate is therefore a liquid which is in contact with a liquid from the body, the blood, via the dialyzer 303 and its membrane.
- a connectable removal device 309a, 309b can be used as a sample container in order to examine the dialysate.
- a suitable sampling point is located, for example, in line 307. If such a sampling point is not available, the sampling device 309b can also be used directly at the machine exit in order to take and examine a dialysate sample.
- Line 306 represents another tapping point. In the area Acute and peritoneal dialysis bags are often used
- these bags can also be equipped with test strips, sample containers or
- test strip In the case of cloudy liquids such as blood in particular, it is within the scope of the invention to separate the test strip from the liquid to be examined with a semipermeable membrane.
- the pores of this membrane are large enough to allow the analyte or analytes to pass through, but at the same time small enough to be disruptive
- sample containers 8a, 8b, 8c can in the
- Embodiment of Figure 5 be prefilled with a preferably isotonic solution, so that an analyte, if present in the liquid in the liquid space 2, then passes through the membrane by means of diffusion.
- a syringe-like removal device is used as in the embodiment of FIG. 7, a passage in the syringe cylinder 11 being provided with a membrane, a pre-filling is not necessary, since the piston 12 does not diffuse, but convection is the driving force due to the piston 12 moving in the syringe cylinder 11 is to convey any substance to the test strip.
- FIG. 9 shows a modified embodiment of the liquid system 1, which essentially corresponds to the embodiment according to FIG. 1, so that reference is made to the relevant description and only deviations are described below.
- the test strip 100 is in a bypass 13. Accordingly, a test strip 100 can be arranged in the bypass 13, which is designed here as a bypass line.
- the bypass 13 is interchangeable with the liquid line 4, but can also on any other
- bypass 13 with the test strip 100 can be exchanged in a particularly simple manner without the catheter 6 having to be separated from the collecting bag 1.
- the bypass 13 is connected to an integrated test strip 100 preferably via penetration of a connection point 14 which has a self-sealing membrane or a valve.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Dentistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102018122024.3A DE102018122024A1 (en) | 2018-09-10 | 2018-09-10 | System for the analysis of liquids coming from or in contact with the body |
PCT/EP2019/074115 WO2020053212A1 (en) | 2018-09-10 | 2019-09-10 | System for analysing fluids originating from the body or fluids in contact with fluids originating from the body |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3849625A1 true EP3849625A1 (en) | 2021-07-21 |
Family
ID=67982038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19769417.7A Pending EP3849625A1 (en) | 2018-09-10 | 2019-09-10 | System for analysing fluids originating from the body or fluids in contact with fluids originating from the body |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3849625A1 (en) |
DE (1) | DE102018122024A1 (en) |
WO (1) | WO2020053212A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111481396A (en) * | 2020-05-08 | 2020-08-04 | 李巧龄 | Hysteroscope and minimally invasive mixed operating room equipment for collecting liquid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4846005A (en) * | 1986-12-12 | 1989-07-11 | Baxter International Inc. | Set with attachable sample cell |
US5577499A (en) * | 1994-10-03 | 1996-11-26 | Teves; Leonides Y. | Blood analyzer |
WO2008141022A1 (en) * | 2007-05-08 | 2008-11-20 | Superior Medical, Llc | Methods and devices for detecting organisms causing urinary tract infections |
US20130172781A1 (en) * | 2011-10-21 | 2013-07-04 | Dale Medical Products, Inc. | pH INDICATOR MODULE FOR GASTRIC TUBES |
US20180149635A1 (en) * | 2015-04-30 | 2018-05-31 | Digisense Ltd. | Sensor |
WO2018058077A1 (en) * | 2016-09-23 | 2018-03-29 | University Of Florida Research Foundation, Inc. | System and method for urinary catheter bacterial detection |
-
2018
- 2018-09-10 DE DE102018122024.3A patent/DE102018122024A1/en active Pending
-
2019
- 2019-09-10 EP EP19769417.7A patent/EP3849625A1/en active Pending
- 2019-09-10 WO PCT/EP2019/074115 patent/WO2020053212A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020053212A1 (en) | 2020-03-19 |
DE102018122024A1 (en) | 2020-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19882693B4 (en) | On-line sensor assembly for measuring a bioanalyte such as lactate | |
EP1177759B1 (en) | Microdialysis device | |
DE69918859T2 (en) | SYSTEM FOR MEASURING A BIOANALYTE SUCH AS LACTAT | |
AT397610B (en) | DEVICE FOR TAKING BODY LIQUIDS | |
DE102006050272B4 (en) | Hemodialysis machine, hemodiafiltration device, method of sampling such devices, and sampling set for use with such devices and methods | |
DE69724188T2 (en) | Arrangement for the analysis of body fluids | |
EP0246451B1 (en) | Apparatus for determining the partial gas pressures in the blood | |
DE4424267C2 (en) | Device for the continuous acquisition of blood parameters | |
DE2538014A1 (en) | DEVICE FOR DIAGNOSIS OF LIQUID SAMPLE | |
EP0367752B1 (en) | Device for determining the concentration of at least one substance in living tissue | |
DE69728525T2 (en) | BY VACUUM IMPROVED TRANSDERMALER LIQUID TRANSPORT | |
EP2307072B1 (en) | Device for peritoneal dialysis | |
EP1129778A2 (en) | System for determining the concentration of an analyte in body fluids | |
CH702752A1 (en) | Coupling part of a drainage tube unit. | |
EP1576341B1 (en) | Device for determining the blood flow in a vessel of a patient | |
EP3365043B1 (en) | Intermediate element for a medical extracorporeal fluid conduit | |
DE4201928A1 (en) | HOLLOW NEEDLE FOR VISCOSITY MEASUREMENT OF LIQUIDS | |
EP1870033A1 (en) | Devices and method for detecting an analyte | |
DE102019121840A1 (en) | Medical sample / collection container with a test field and an absorber unit | |
WO2020053212A1 (en) | System for analysing fluids originating from the body or fluids in contact with fluids originating from the body | |
WO2010103051A1 (en) | Sampling device and sampling method | |
WO1999053835A1 (en) | Device and method for measuring intravascular pressure and for low contaminating introduction of catheters, for example, in blood vessels | |
EP0958780B1 (en) | Sensor system with permanently implanted access | |
EP2405802B1 (en) | Sampling device and sampling method | |
WO2021028543A1 (en) | Medical fluid sampling system comprising a sample-/sampling container having a culture medium or test strip, and culture medium preparation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210317 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230829 |